Mark Jacobs, MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 1010 West Chester Pike, Suite #202, Havertown, PA 19083 Phone: 610-789-3510 Fax: 610-789-3591 |
Dr. Philip Brian Gilman, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1010 W Chester Pike, Suite 202, Havertown, PA 19083 Phone: 610-789-3510 Fax: 610-789-3591 |
Jacques Khoury, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 2050 W Chester Pike, Suite 200, Havertown, PA 19083 Phone: 610-449-1525 Fax: 610-853-3687 |
Dr. Yih-fu Shiau, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 21 N Eagle Rd, Havertown, PA 19083 Phone: 610-446-3350 Fax: 610-446-3706 |
Rita Lorraine Ritsema, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1010 West Chester Pike, Ste #202, Havertown, PA 19083 Phone: 610-789-3510 Fax: 610-789-3591 |
News Archive
It is the cosmetic treatment many women have dreamed of - taking the fat from their hips and thighs and redistributing it to their breasts. But many people question whether this procedure is safe or effective.
Health People (HP) announced today the launch of its new Centers for Disease Control and Prevention (CDC)-recognized Diabetes Prevention Program for Bronx residents to help the borough combat its high diabetes-related death rate - the highest in the city.
Marketwatch/The Seattle Times reports on the looming 21 percent cut to physicians' Medicare payments. "The cut was to take effect March 1 until Congress delayed it by 30 days. The Senate then voted last Wednesday to postpone the cut an additional six months as part of a larger bill that extends unemployment benefits. The measure now moves to the House."
Premature babies make fewer friends, feel less accepted by peers and spend less time socializing in early childhood - but this improves when they get to school - according to new research by an international research collaboration, including the University of Warwick, UK.
The Board of Directors of CELLINK AB (publ) has, based on the authorization given by the Company's Annual General Meeting that was held on 18 December 2019, resolved on a directed share issue of 3,890,000 new shares of series B (corresponding to approximately 10 per cent of the total number of outstanding shares in the Company) at a subscription price of SEK 97 per share (the "Share Issue"), which means that the Company receives SEK 377,330,000 before transaction costs.
› Verified 1 days ago